Ved samtidig administration med ritonavir kan serumkoncentrationerne øges, hvilket resulterer i en potentiel øget forekomst af bivirkninger.
Serum concentrations may be increased when co-administered with ritonavir resulting in the potential for increased incidence of adverse events.